Merck · 5 hours ago
2026 Future Talent Program - Agentic AI - Co-Op
Merck is a leading company in the pharmaceutical industry, and they are seeking a motivated Co-op student to join their Computational Toxicology team. This role involves applying machine learning and natural language processing to enhance drug safety assessments and develop AI pipelines that integrate various toxicology datasets.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Develop and evaluate predictive models to assess compound safety risks and identify toxicity mechanisms using multimodal pharmaceutical data
Design and implement NLP/LLM pipelines (prompt engineering, fine-tuning, retrieval-augmented generation, etc.) to extract insights from unstructured reports and biomedical literature
Build and deploy interactive dashboards (e.g., Streamlit, Dash) to visualize and communicate findings to toxicologists, chemists, and project teams
Collaborate with multidisciplinary scientists across toxicology, chemistry, and data science to translate computational outputs into actionable safety insights
Qualification
Required
Currently pursuing a Ph.D. in Computational Science, Data Science, Bioinformatics, Computational Biology/Chemistry, Computational Linguistics, or a related field
Experienced with NLP and LLM frameworks (e.g., Hugging Face, spaCy, NLTK) and techniques such as prompt design, fine-tuning, and retrieval-augmented generation (RAG)
Proficient in Python, with strong skills in statistics, data wrangling (pandas/SQL), and model development (scikit-learn, PyTorch, TensorFlow)
Familiar with Git/GitHub workflows
Passionate about applying AI to improve human safety, reduce animal testing, and transform decision-making in drug discovery
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2025-12-30
2025-12-30
BioWorld Financial Watch
2025-12-29
Company data provided by crunchbase